|
NUP88 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.381800E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.462400E-01 |
| Normal-vs-Stage2 |
8.531800E-01 |
| Normal-vs-Stage3 |
8.773000E-01 |
| Normal-vs-Stage4 |
1.916160E-01 |
| Stage1-vs-Stage2 |
7.689200E-01 |
| Stage1-vs-Stage3 |
9.544000E-01 |
| Stage1-vs-Stage4 |
2.672600E-01 |
| Stage2-vs-Stage3 |
7.979400E-01 |
| Stage2-vs-Stage4 |
2.714600E-01 |
| Stage3-vs-Stage4 |
3.808000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.627200E-01 |
| Normal-vs-AfricanAmerican |
6.987000E-01 |
| Normal-vs-Asian |
2.486000E-01 |
| Caucasian-vs-AfricanAmerican |
6.591200E-01 |
| Caucasian-vs-Asian |
3.060600E-01 |
| AfricanAmerican-vs-Asian |
2.871800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.183200E-01 |
| Normal-vs-Female |
7.863800E-01 |
| Male-vs-Female |
6.358600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.134400E-01 |
| Normal-vs-Extreme_Weight |
2.953000E-01 |
| Normal-vs-Obese |
5.928600E-01 |
| Normal-vs-Extreme_Obese |
7.588200E-01 |
| Normal_Weight-vs-Extreme_Weight |
6.553000E-01 |
| Normal_Weight-vs-Obese |
1.254790E-01 |
| Normal_Weight-vs-Extreme_Obese |
7.835200E-01 |
| Extreme_Weight-vs-Obese |
1.716780E-01 |
| Extreme_Weight-vs-Extreme_Obese |
9.512200E-01 |
| Obese-vs-Extreme_Obese |
5.492600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.236000E-01 |
| Normal-vs-Age(41-60Yrs) |
3.160200E-01 |
| Normal-vs-Age(61-80Yrs) |
3.961800E-01 |
| Normal-vs-Age(81-100Yrs) |
7.096300E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.745800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.750420E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.716340E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.530000E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.205570E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.002650E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
6.271800E-02 |
| Normal-VS-Type2 PRCC |
8.600400E-03 |
| Normal-VS-KIRP CIMP |
2.635200E-01 |
| Normal-VS-Unclassified PRCC |
5.040200E-01 |
| Type1 PRCC-VS-Type2 PRCC |
2.27629999999257E-05 |
| Type1 PRCC-VS-KIRP CIMP |
6.630600E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
6.537800E-02 |
| Type2 PRCC-VS-KIRP CIMP |
3.145600E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
2.115200E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
1.845040E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.222000E-02 |
| Normal-vs-N1 |
3.536800E-01 |
| Normal-vs-N2 |
3.386800E-04 |
| N0-vs-N1 |
2.680400E-02 |
| N0-vs-N2 |
1.475360E-01 |
| N1-vs-N2 |
3.138400E-02 |
|
|
